Drug recall · December 18, 2013
Diovan (valsartan) 320 mg per tablet recall
Why: Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diovan (valsartan) 320 mg per tablet, 7 Tablets per bottle, Rx only Physician Sample Not For Sale, Manufactured by: Novartis Pharmaceuticals Corporation Suffern, NY 10901 for Novartis Pharmaceuticals Corporation East Hanover, NJ 07936, NDC # 0078-9360-07
- Lots / codes
Product code: 704414; Lot Number: F1027; Exp 2/28/2014
- Quantity
- 57,881 bottles
- Company
- Novartis Pharmaceuticals Corp., Suffern, NY
- Distribution
- Nationwide and Puerto Rico
- Initiated
- August 8, 2013 · Voluntary: Firm initiated
- Classified
- December 6, 2013
- Reported
- December 18, 2013
- Ended
- December 21, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valsartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.